EVALUATION OF RESPIRATORY MECHANICS AND FUNCTIONALITY IN PATIENTS WITH CHRONIC OBSTRUCTIVE PULMONARY DISEASE
NCT ID: NCT03086590
Last Updated: 2018-11-07
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
20 participants
OBSERVATIONAL
2016-11-01
2018-03-01
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Efficacy of Costal Mobilization Techniques and Manual Diaphragm Release Technique in Patients COPD
NCT03022942
Diaphragmatic Mobility and Chronic Obstructive Pulmonary Disease
NCT00870246
Functional Tests in Individuals With Chronic Obstructive Pulmonary Disease (COPD)
NCT00660738
Analysis of Muscle Oxygen Saturation and Functional Variables During Physical Capacity Assessments in Patients With COPD
NCT06968273
Effect of Expiratory Positive Pressure on Dynamic Hyperinflation and Ability to Exercise With Upper Limbs in COPD
NCT03073564
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
CROSS_SECTIONAL
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Group 1
COPD mild. The individuals allocated to this group have FEV1 ≥ 80% predicted.
No interventions assigned to this group
Group 2
COPD Moderate. The individuals allocated to this group have 50% ≤ FEV1 \< 80% predicted.
No interventions assigned to this group
Group 3
COPD Severe. The individuals allocated to this group have 30% ≤ FEV1 \< 50% predicted.
No interventions assigned to this group
Group 4
COPD Very severe. The individuals allocated to this group have FEV1 \< 30% predicted.
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* Heart diseases;
* Those who are in some previous training program or rehabilitation;
21 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Universidade Federal de Pernambuco
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Rodrigo Viana Correia de Souza
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Universidade Federal de Pernambuco
Recife, Pernambuco, Brazil
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UFPE-M1
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.